Parsifal Capital Management, LP
In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 15, 2024), Parsifal Capital Management, LP reported 19 stock positions worth $1.4 billion. Its top holding was Sharkninja (SN) at 13.6% of the portfolio, followed by Hilton Grand Vacations (HGV, 12.0%) and Albertsons Cos Class A (ACI, 10.1%). Compared with Q4 2023, it opened 6 new positions, sold out of 6, added to 1 and reduced 12. The biggest buy was a new position in Albertsons Cos Class A (ACI) and the biggest sale an exit from Rover (ROVR).
- Most Recent 13F
- Q2 2026
- Location
- GREENWICH, CT
- CIK
- 0001776090
- Portfolio Value
- $1.4B (Q1 2024)
- SEC Filing
- 0001776090-24-000004 ↗ filed May 15, 2024
Holdings Value
Holdings 19 stocks · $1.4B
| SN Sharkninja Inc. | 13.56% | 3,153,997 | $196.5M | Reduce -0.6% |
| HGV Hilton Grand Vacations Inc. | 11.97% | 3,673,453 | $173.4M | Reduce -7.8% |
| ACI Albertsons Cos Inc. Class A | 10.08% | 6,808,813 | $146.0M | New |
| CLX Clorox Company | 8.83% | 835,614 | $127.9M | Reduce -7.1% |
| BRSL Brightstar Lottery PLC filed as INTERNATIONAL GAME TECHNOLOG | 6.54% | 4,195,975 | $94.8M | Reduce -2.2% |
| AER Aercap Holdings NV | 6.20% | 1,033,626 | $89.8M | Reduce -42.7% |
| CI The Cigna Group | 5.78% | 230,576 | $83.7M | Add +23.4% |
| LW Lamb Weston Holdings Inc. | 5.34% | 726,240 | $77.4M | Reduce -35.0% |
| NTNX Nutanix Inc. Class A | 5.08% | 1,192,799 | $73.6M | Reduce -10.1% |
| TEVA Teva Pharmaceutical-SP ADR | 4.92% | 5,048,300 | $71.2M | New |
| BIO Bio-Rad Laboratories-A | 4.25% | 178,013 | $61.6M | Reduce -7.1% |
| WDC Western Digital Corp. | 3.42% | 725,500 | $49.5M | New |
| ELV Elevance Health Inc. | 3.12% | 87,108 | $45.2M | Reduce -6.8% |
| TKO Tko Group Holdings Inc. | 2.67% | 447,000 | $38.6M | New |
| KR Kroger Co. | 2.56% | 648,611 | $37.1M | Reduce -49.6% |
| LLY Eli Lilly & Co. | 2.41% | 44,800 | $34.9M | New |
| ATMU Atmus Filtration Technologie | 1.46% | 655,469 | $21.1M | New |
| CCC CCC Intelligent Solutions Ho | 1.40% | 1,692,912 | $20.2M | Reduce -53.9% |
| MTCH Match Group Inc. | 0.40% | 161,193 | $5.8M | Reduce -91.1% |
Portfolio Sells Q4 2023 → Q1 2024
| ROVR Rover Group Inc. | Sold out | 0.00% | −5.36 |
| MTCH Match Group Inc. | Reduce -91.1% | 0.40% | −4.11 |
| BABA Alibaba Group Holding-SP ADR | Sold out | 0.00% | −3.43 |
| AWK American Water Works Co. Inc. | Sold out | 0.00% | −3.05 |
| AER Aercap Holdings NV | Reduce -42.7% | 6.20% | −3.00 |
| LW Lamb Weston Holdings Inc. | Reduce -35.0% | 5.34% | −2.94 |
| BURL Burlington Stores Inc. | Sold out | 0.00% | −2.16 |
| RCM R1 RCM Inc. | Sold out | 0.00% | −1.64 |
| BRSL Brightstar Lottery PLC | Reduce -2.2% | 6.54% | −1.53 |
| KR Kroger Co. | Reduce -49.6% | 2.56% | −1.48 |
| CCC CCC Intelligent Solutions Ho | Reduce -53.9% | 1.40% | −1.48 |
| WSC Willscot Holdings Corp. | Sold out | 0.00% | −0.97 |
| BIO Bio-Rad Laboratories-A | Reduce -7.1% | 4.25% | +0.00 |
| CLX Clorox Company | Reduce -7.1% | 8.83% | +0.03 |
| ELV Elevance Health Inc. | Reduce -6.8% | 3.12% | +0.09 |
| NTNX Nutanix Inc. Class A | Reduce -10.1% | 5.08% | +0.74 |
| HGV Hilton Grand Vacations Inc. | Reduce -7.8% | 11.97% | +0.98 |
| SN Sharkninja Inc. | Reduce -0.6% | 13.56% | +2.42 |
Portfolio Buys Q4 2023 → Q1 2024
| ACI Albertsons Cos Inc. Class A | New | 10.08% | +10.08 |
| TEVA Teva Pharmaceutical-SP ADR | New | 4.92% | +4.92 |
| WDC Western Digital Corp. | New | 3.42% | +3.42 |
| TKO Tko Group Holdings Inc. | New | 2.67% | +2.67 |
| LLY Eli Lilly & Co. | New | 2.41% | +2.41 |
| CI The Cigna Group | Add +23.4% | 5.78% | +1.94 |
| ATMU Atmus Filtration Technologie | New | 1.46% | +1.46 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 14 | $816.5M | COMP, HGV, SN, AXTA, AKAM |
| Q1 2026 | 17 | $774.6M | COMP, HGV, SN, AKAM, AXTA |
| Q4 2025 | 15 | $992.6M | SN, HGV, GMED, TEVA, GXO |
| Q3 2025 | 16 | $1.1B | AVPT, ACI, SN, DLTR, HGV |
| Q2 2025 | 13 | $1.0B | ACI, DLTR, MMM, SN, HGV |
| Q1 2025 | 15 | $956.2M | ACI, HGV, MMM, SN, AVPT |
| Q4 2024 | 16 | $1.2B | ACI, HGV, SN, MMM, CLX |
| Q3 2024 | 14 | $1.3B | ACI, SN, HGV, CLX, TEVA |
| Q2 2024 | 18 | $1.4B | SN, HGV, ACI, CLX, TEVA |
| Q1 2024 | 19 | $1.4B | SN, HGV, ACI, CLX, BRSL |